Brand New, Unread Copy in Perfect Condition. A+ Customer Service! Summary: With contributions by numerous experts. Codice inventario libreria
Riassunto: "CNS neuroprotection" was a common subject of papers, symposia, and reviews during the previous "decade of the brain. " Indeed, in recent years, experimental study of putative neuroprotective agents prompted clinical trials of numerous drug candidates in acute and chronic human neurodegenerative conditions. While the outcomes of these trials have not been as successful as initially hoped, these were early explorations, and the pipeline of relevant ideas continues to grow in strength and depth. We predict that early in this new millennium, crippling disorders such as stroke and Alzheimer's disease will be treated effectively by therapeutic neuroprotective strategies. This volume of the Handbook of Experimental Pharmacology titled eNS Neuroprotection provides a pharmacological perspective on currently promis ing neuroprotective approaches, and a clinical perspective on the challenges involved in establishing the efficacy of these approaches through appropriate clinical trials. Section I, "Mechanistic Approaches to CNS Neuroprotection," reviews major injury mechanisms that have formed the basis for many past and present clinical trials conducted around the world. Dr. KIM and colleagues, Washington University School of Medicine, review the status of blocking excitotoxicity as an approach to CNS neuroprotection. Dr. WANG, Pfizer Global Research and Development,Ann Arbor Laboratories, outlines evidence supporting a contri bution of apoptosis to pathological neuronal or glial cell loss. Drs. BECKER and HALLENBECK, University of Washington and the National Institute on Neuro logical Diseases and Stroke, respectively, argue that inhibiting inflammatory pathways in the brain can be neuroprotective. Dr.
Sinossi: This volume is a review which presents both a basic science and clinical perspective on neuroprotective approaches to acute and chronic neurodegenerative conditions. Experts from both fields review current areas of neuroprotection. The book describes basic science discovery in stroke research and the application of such research within the pharmaceutical industry leading to the development of neuroprotective drugs.
Condizione libro: New
Descrizione libro Springer, 2010. Paperback. Condizione libro: NEW. 9783642076251 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Codice libro della libreria HTANDREE0399948
Descrizione libro Springer, 2010. Paperback. Condizione libro: New. Softcover reprint of hardcover 1. This item is printed on demand. Codice libro della libreria DADAX3642076254
Descrizione libro Springer, 2010. Condizione libro: New. This item is printed on demand for shipment within 3 working days. Codice libro della libreria LP9783642076251
Descrizione libro Springer, 2010. Paperback. Condizione libro: Brand New. softcover reprint of hardcover 1st ed. 2002 edition. 528 pages. 8.80x5.90x1.20 inches. In Stock. Codice libro della libreria 3642076254
Descrizione libro Springer, 2010. Paperback. Condizione libro: Good. Ships with Tracking Number! INTERNATIONAL WORLDWIDE Shipping available. May not contain Access Codes or Supplements. Buy with confidence, excellent customer service! Softcover reprint of the original 1st ed. 2002. Codice libro della libreria 3642076254